BeiGene Enters New Phase to Expand US Manufacturing and R&D Footprint

BeiGene, a global biotechnology company, has entered a new phase in building its US presence by placing the last piece of structural steel at its Hopewell campus today. This new facility will provide state-of-the-art commercial-stage U.S. biologic pharmaceutical manufacturing, late-stage research and clinical development capabilities that complement the company’s existing capabilities around the world.